ArticleCellular and molecular life sciences : CMLS2026
TIA1-mediated stress granules inhibit the neuroinflammation and neurodegeneration after spinal cord injury through LCN2 signaling.
Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Spinal cord injury (SCI), a complex and serious neurological disease may induce severe cellular stress. In response to stress signals, cells form stress granules (SGs) as protective measures, and T-cell intracellular antigen 1 (TIA1) is a vital component of SGs. However, the roles and mechanism of TIA1-mediated SGs in SCI remain unknown. In this study, we found that TIA1 was upregulated in the cytoplasm of neurons and co-localized with the cytoplasmic G3BP1+ SGs. Furthermore, Tia1 knockout in the CNS (Tia1Nestin-CKO mice) did not affect the development of the spinal cords and locomotion function, but impeded the neural regeneration, and then inhibited the functional recovery after SCI, whereas, Tia1 knockout in the astrocytes (Tia1GFAP-CKO mice) did not affect development of the spinal cords and the locomotion functional recovery after SCI. Mechanistically, we found that Tia1 deletion decreased the formation of SGs, and increased the lipocalin 2 (LCN2, a secreted protein) expression in neurons through decreasing the sequestration of their mRNA into SGs after SCI, which further induced the neuroinflammation by activating astrocytes and microglia through cGAS-STING signaling pathway. Finally, treatment with deferoxamine (DFO), an inhibitor of LCN2, inhibited the neuroinflammation and partially restored the deficits in neural degeneration and functional recovery after SCI in Tia1Nestin-CKO mice. Together, these results suggest neuronal TIA1-mediated SGs encapsulates lcn2 mRNA, halting its translation and thereby attenuating the neuroinflammation and promoted the functional recovery after SCI, and TIA1-mediated SGs serves as a novel strategy for SCI treatment by regulating neuroinflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.